Preclinical studies with JAA-F11 anti-Thomsen-Friedenreich monoclonal antibody for human breast cancer (Q39021852)

8 September 2017

title

Preclinical studies with JAA-F11 anti-Thomsen-Friedenreich monoclonal antibody for human breast cancer (English)

1 reference

8 September 2017

1 reference

Kate Rittenhouse-Olson

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559446%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Kimiko Ferguson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559446%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Arti Yadav

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559446%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Susan Morey

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559446%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Julia Abdullah

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559446%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Gabriel Hrysenko

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559446%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Jing Ying Eng

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559446%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Munawwar Sajjad

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559446%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Stephen Koury

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559446%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

language of work or name

English

0 references

publication date

1 February 2014

1 reference

8 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559446%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559446%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559446%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

385-399

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559446%20AND%20SRC:MED&resulttype=core&format=json

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.209

Bevacizumab for the first-line treatment of human epidermal growth factor receptor 2-negative advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.209

Adhesion or anti-adhesion in cancer: what matters more?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.209

Tumor immunolocalization using 124 I-iodine-labeled JAA-F11 antibody to Thomsen-Friedenreich alpha-linked antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.209

Blood group MN precursors as human breast carcinoma-associated antigens and "naturally" occurring human cytotoxins against them

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.209

Human carcinoma-associated precursor antigens of the NM blood group system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.209

Novel INTeraction of MUC4 and galectin: potential pathobiological implications for metastasis in lethal pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.209

Jaa-f11: extending the life of mice with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.209

Development and characterization of monoclonal antibody to T-antigen: (gal beta1-3GalNAc-alpha-O).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.209

Inhibition of spontaneous breast cancer metastasis by anti-Thomsen-Friedenreich antigen monoclonal antibody JAA-F11

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.209

In vivo tumor cell adhesion in the pulmonary microvasculature is exclusively mediated by tumor cell--endothelial cell interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.209

Management of triple negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.209

Systematic variation in gene expression patterns in human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.209

MDA-MB-435 and M14 cell lines: identical but not M14 melanoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.209

A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.209

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.209

Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.209

PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.209

Antineoplastic effects of an Aurora B kinase inhibitor in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.209

Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.209

Anti-Thomsen-Friedenreich-Ag (anti-TF-Ag) potential for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.209

Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.209

Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.209

T-antigen in normal and neoplastic urothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.209

Correlative fine specificity of several Thomsen-Friedenreich disaccharide-binding proteins with an effect on tumor cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.209

Comment Re: MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.209